论文部分内容阅读
本院应用大塚药厂生产的新型输液剂M3A用于腹泻脱水补充累积损失及R4A用于新生儿生理需要量,对照观察其血糖与电解质的影响,现报道如下。腹泻脱水用M3A液补充累积损失的观察
The hospital application of Otsuka Pharmaceutical Factory production of a new type of infusion agent M3A for diarrhea, dehydration supplement cumulative loss and R4A for neonatal physiological requirements, the control of blood glucose and electrolytes, are reported below. Diarrhea dehydration with M3A fluid to supplement the cumulative loss observed